ATE126702T1 - Verfahren zur herstellung von impfstoffen gegen rna-virus. - Google Patents
Verfahren zur herstellung von impfstoffen gegen rna-virus.Info
- Publication number
- ATE126702T1 ATE126702T1 AT90909343T AT90909343T ATE126702T1 AT E126702 T1 ATE126702 T1 AT E126702T1 AT 90909343 T AT90909343 T AT 90909343T AT 90909343 T AT90909343 T AT 90909343T AT E126702 T1 ATE126702 T1 AT E126702T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- rna virus
- virus
- vaccines against
- against rna
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001086 cytosolic effect Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 241001493065 dsRNA viruses Species 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898913665A GB8913665D0 (en) | 1989-06-14 | 1989-06-14 | Method of preparing vaccines against rna viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE126702T1 true ATE126702T1 (de) | 1995-09-15 |
Family
ID=10658419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90909343T ATE126702T1 (de) | 1989-06-14 | 1990-06-12 | Verfahren zur herstellung von impfstoffen gegen rna-virus. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0477240B1 (de) |
| JP (1) | JP2973372B2 (de) |
| AT (1) | ATE126702T1 (de) |
| AU (1) | AU637114B2 (de) |
| CA (1) | CA2060198C (de) |
| DE (1) | DE69021879T2 (de) |
| GB (1) | GB8913665D0 (de) |
| WO (1) | WO1990015622A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1267591A (en) * | 1969-02-26 | 1972-03-22 | Nat Res Dev | Antigenic materials |
| IL68219A0 (en) * | 1982-03-24 | 1983-06-15 | Univ Birmingham | Vaccine against dna viruses |
| NZ225583A (en) * | 1987-08-06 | 1991-07-26 | Merck & Co Inc | Process for purifying hepatitis a virions (hav) |
-
1989
- 1989-06-14 GB GB898913665A patent/GB8913665D0/en active Pending
-
1990
- 1990-06-12 JP JP2508641A patent/JP2973372B2/ja not_active Expired - Fee Related
- 1990-06-12 AT AT90909343T patent/ATE126702T1/de not_active IP Right Cessation
- 1990-06-12 DE DE69021879T patent/DE69021879T2/de not_active Expired - Fee Related
- 1990-06-12 CA CA002060198A patent/CA2060198C/en not_active Expired - Fee Related
- 1990-06-12 AU AU58326/90A patent/AU637114B2/en not_active Ceased
- 1990-06-12 EP EP90909343A patent/EP0477240B1/de not_active Expired - Lifetime
- 1990-06-12 WO PCT/GB1990/000905 patent/WO1990015622A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0477240B1 (de) | 1995-08-23 |
| CA2060198C (en) | 2000-05-02 |
| CA2060198A1 (en) | 1990-12-15 |
| JPH04506209A (ja) | 1992-10-29 |
| JP2973372B2 (ja) | 1999-11-08 |
| AU5832690A (en) | 1991-01-08 |
| WO1990015622A1 (en) | 1990-12-27 |
| DE69021879T2 (de) | 1996-04-04 |
| EP0477240A1 (de) | 1992-04-01 |
| AU637114B2 (en) | 1993-05-20 |
| DE69021879D1 (de) | 1995-09-28 |
| GB8913665D0 (en) | 1989-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712592A (pt) | Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico | |
| FI932678A0 (fi) | Pao alfavirus baserande DNA expressionssystem | |
| DE69333814D1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
| ATE542891T1 (de) | Verfahren zur herstellung von biologischen produkten in protein-freier kultur | |
| CY1110359T1 (el) | Εμβολια με βαση σιρκοϊους χοιρων | |
| AU2684792A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
| ATE140031T1 (de) | Rekombinante poxvirusinnenkerne | |
| EE200300331A (et) | Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin | |
| ATE420189T1 (de) | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus | |
| EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
| BR0016145A (pt) | Clones infecciosos | |
| DE68915165D1 (de) | Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
| TW377373B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease | |
| DK157186D0 (da) | Ekspression af immunologisk aktive virale proteiner | |
| ATE365206T1 (de) | Verfahren zur entwicklung von einem hiv impfstoff | |
| ATE36956T1 (de) | Verfahren zu herstellung von lebenden, adjuvierten impfstoffen und so erhaltende lebende, adjuvierte impfstoffe. | |
| SE9903031D0 (sv) | Peptide mixture and vaccine against a chronic viral infection | |
| EP0236977A3 (de) | Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera | |
| ATE126702T1 (de) | Verfahren zur herstellung von impfstoffen gegen rna-virus. | |
| BRPI0209416A8 (pt) | novos vetores de expressão e uso dos mesmos | |
| AU5573196A (en) | A pluripotent vaccine against enveloped viruses | |
| FI923020A0 (fi) | Inte a inte b-sekvenser. | |
| BR0014861A (pt) | Partìculas virais com epìtopos internos exógenos | |
| NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
| RU98116217A (ru) | Способ получения белка с использованием трансляционной системы митохондрий |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |